1-1703490-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_024011.4(CDK11A):āc.2046C>Gā(p.Phe682Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000078 ( 0 hom., cov: 17)
Exomes š: 0.0000050 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CDK11A
NM_024011.4 missense
NM_024011.4 missense
Scores
1
2
15
Clinical Significance
Conservation
PhyloP100: -0.343
Genes affected
CDK11A (HGNC:1730): (cyclin dependent kinase 11A) This gene encodes a member of the serine/threonine protein kinase family. Members of this kinase family are known to be essential for eukaryotic cell cycle control. Due to a segmental duplication, this gene shares very high sequence identity with a neighboring gene. These two genes are frequently deleted or altered in neuroblastoma. The protein kinase encoded by this gene can be cleaved by caspases and may play a role in cell apoptosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.26256382).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDK11A | NM_024011.4 | c.2046C>G | p.Phe682Leu | missense_variant | 18/20 | ENST00000404249.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDK11A | ENST00000404249.8 | c.2046C>G | p.Phe682Leu | missense_variant | 18/20 | 1 | NM_024011.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000778 AC: 1AN: 128556Hom.: 0 Cov.: 17
GnomAD3 genomes
AF:
AC:
1
AN:
128556
Hom.:
Cov.:
17
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000486 AC: 8AN: 164702Hom.: 0 AF XY: 0.0000226 AC XY: 2AN XY: 88360
GnomAD3 exomes
AF:
AC:
8
AN:
164702
Hom.:
AF XY:
AC XY:
2
AN XY:
88360
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000500 AC: 7AN: 1400326Hom.: 0 Cov.: 30 AF XY: 0.00000289 AC XY: 2AN XY: 692316
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
7
AN:
1400326
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
692316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000778 AC: 1AN: 128556Hom.: 0 Cov.: 17 AF XY: 0.00 AC XY: 0AN XY: 62200
GnomAD4 genome
AF:
AC:
1
AN:
128556
Hom.:
Cov.:
17
AF XY:
AC XY:
0
AN XY:
62200
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.2046C>G (p.F682L) alteration is located in exon 18 (coding exon 17) of the CDK11A gene. This alteration results from a C to G substitution at nucleotide position 2046, causing the phenylalanine (F) at amino acid position 682 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;.;.;N
MutationTaster
Benign
D;D;D;D;D;D
PROVEAN
Benign
N;N;N;N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T
Polyphen
0.98
.;.;D;.;D;.
Vest4
MutPred
0.58
.;.;Gain of ubiquitination at K687 (P = 0.0846);.;.;.;
MVP
MPC
0.23
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at